A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: distribute (102), allot (2)

Lenvatinib(59kg or less)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where eith
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

Acalabrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treatment of chronic lymphocytic leukaemia (CLL) prior to EU
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf

Papers Trust Board - 13 January 2026

Description
Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

Epcoritamab -Cycle 1 (Priming)

Description
Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymp
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

EC-DPH IV (Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab IV)

Description
Please refer to the most up to date Bluteq eligibility criteria for pertuzumab and trastuzumab before prescribing.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/EC-DPH-IV-Cyclophosphamide-Epirubicin-Docetaxel-Pertuzumab-Trastuzumab-IV.pdf

VenetoclaxLow

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen • CLL – Venetoclax (low risk) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

Appendix A - Algorithm for the completion of monthly returns

Description
Algorithm for the completion of monthly returns for VZIG, HBIG200IU, HBIG500IU and RIG/rabies vaccine"PHE Colindale", "UHS Pharmacy" and "PHE
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixA-Algorithmforthecompletionofmonthlyreturns.pdf

Rabies Ig and vaccine UHS prescription

Description
Please note that Rabies Ig will be issued only when the UHS Pharmacy receives both this PRESCRIPTION and the RISK ASSESSEMENT
Url
/Media/SUHTExtranet/DepartmentOfInfection/Immunoglobulins/Rabies-Ig-and-Vaccine-UHS-Prescription.pdf

Gefitinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEFITINIB Regimen NSCLC - Gefitinib Indication Gefitinib is recommended as an option for the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gefitinibver13.pdf

Appendix K - HAV information re post-exposure treatment

Description
HAV,post-exposure
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixK-HAVinformationrepostexposuretreatment.pdf
91 to 100 of 181
Previous … 8 9 10 11 12 … Next